$0.49
+0.01 (+1.02%)
USD · as of 2026-08-18 · marketstack
Clinical trials
catalyst calendar across sponsors →Studies where MLSS is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
1 interventional
Held by 1 tracked-famous manager (RENAISSANCE TECHNOLOGIES LLC) · FINRA short interest 1.0 days to cover (settled 2026-07-31) · government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|---|
| CompuFlo® Assessment Study for the Epidural Space VerificationNCT02378727Primary Effectiveness Objective (successful performance of lumbar epidural procedure)Randomized · Open-label · Diagnostic | Not applicable | Unknown status | Device: Active: Comparator Loss Of Resistance Syringe, Experimental: CompuFlo® Epidural System | Verification of Needle Tip Placement in the Lumbar Epidural Space | 400 | Jul 2016 | 2016-07-06 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19